User profiles for "author:K Ounap"

Katrin Ounap

University of Tartu, Institute of Clinical Medicine
Verified email at broadinstitute.org
Cited by 8078

Expert consensus document: Clinical and molecular diagnosis, screening and management of Beckwith-Wiedemann syndrome: an international consensus statement …

F Brioude, JM Kalish, A Mussa, AC Foster… - Nat Rev …, 2018 - openaccess.sgul.ac.uk
Beckwith-Wiedemann syndrome (BWS), a human genomic imprinting disorder, is
characterized by phenotypic variability that might include overgrowth, macroglossia …

[HTML][HTML] International clinical guideline for the management of classical galactosemia: diagnosis, treatment, and follow-up

L Welling, LE Bernstein, GT Berry, AB Burlina… - Journal of inherited …, 2017 - Springer
Classical galactosemia (CG) is an inborn error of galactose metabolism. Evidence-based
guidelines for the treatment and follow-up of CG are currently lacking, and treatment and …

[HTML][HTML] Clinical and molecular diagnosis, screening and management of Beckwith–Wiedemann syndrome: an international consensus statement

F Brioude, JM Kalish, A Mussa, AC Foster… - Nature Reviews …, 2018 - nature.com
Abstract Beckwith–Wiedemann syndrome (BWS), a human genomic imprinting disorder, is
characterized by phenotypic variability that might include overgrowth, macroglossia …

A new highly penetrant form of obesity due to deletions on chromosome 16p11. 2

…, M Béri-Dexheimer, P Jonveaux, B Leheup, K Ounap… - Nature, 2010 - nature.com
Obesity has become a major worldwide challenge to public health, owing to an interaction
between the Western 'obesogenic'environment and a strong genetic contribution. Recent …

FGF-21 as a biomarker for muscle-manifesting mitochondrial respiratory chain deficiencies: a diagnostic study

A Suomalainen, JM Elo, KH Pietiläinen… - The Lancet …, 2011 - thelancet.com
Background Muscle biopsy is the gold standard for diagnosis of mitochondrial disorders
because of the lack of sensitive biomarkers in serum. Fibroblast growth factor 21 (FGF-21) is …

[PDF][PDF] High rate of recurrent de novo mutations in developmental and epileptic encephalopathies

FF Hamdan, CT Myers, P Cossette, P Lemay… - The American Journal of …, 2017 - cell.com
Developmental and epileptic encephalopathy (DEE) is a group of conditions characterized
by the co-occurrence of epilepsy and intellectual disability (ID), typically with developmental …

Further delineation of the 15q13 microdeletion and duplication syndromes: a clinical spectrum varying from non-pathogenic to a severe outcome

…, M Fichera, H Stewart, LE Connell, K Ounap… - Journal of medical …, 2009 - jmg.bmj.com
Background: Recurrent 15q13. 3 microdeletions were recently identified with identical
proximal (BP4) and distal (BP5) breakpoints and associated with mild to moderate mental …

Mutations in CTC1, encoding conserved telomere maintenance component 1, cause Coats plus

…, R Mehta, S Naidu, KK Nischal, L Nunes, K Ounap… - Nature …, 2012 - nature.com
Coats plus is a highly pleiotropic disorder particularly affecting the eye, brain, bone and
gastrointestinal tract. Here, we show that Coats plus results from mutations in CTC1 …

Monogenic variants in dystonia: an exome-wide sequencing study

M Zech, R Jech, S Boesch, M Škorvánek… - The Lancet …, 2020 - thelancet.com
Background Dystonia is a clinically and genetically heterogeneous condition that occurs in
isolation (isolated dystonia), in combination with other movement disorders (combined …

Novel (ovario) leukodystrophy related to AARS2 mutations

C Dallabona, D Diodato, SH Kevelam, TB Haack… - Neurology, 2014 - AAN Enterprises
Objectives: The study was focused on leukoencephalopathies of unknown cause in order to
define a novel, homogeneous phenotype suggestive of a common genetic defect, based on …